146 related articles for article (PubMed ID: 14632590)
1. The quality of published adverse drug event reports.
Kelly WN
Ann Pharmacother; 2003 Dec; 37(12):1774-8. PubMed ID: 14632590
[TBL] [Abstract][Full Text] [Related]
2. Inter-rater reliability of a classification system for hospital adverse drug event reports.
Haynes K; Hennessy S; Morales KH; Gibson GA; Barnhart C; Jaipaul CK; Linkin DR
Clin Pharmacol Ther; 2008 Mar; 83(3):485-8. PubMed ID: 17713472
[TBL] [Abstract][Full Text] [Related]
3. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug event reporting in intensive care units: a survey of current practices.
Kane-Gill SL; Devlin JW
Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
[TBL] [Abstract][Full Text] [Related]
5. Performance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system.
Hougland P; Xu W; Pickard S; Masheter C; Williams SD
Med Care; 2006 Jul; 44(7):629-36. PubMed ID: 16799357
[TBL] [Abstract][Full Text] [Related]
6. Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.
Eiden C; Peyrière H; Cociglio M; Djezzar S; Hansel S; Blayac JP; Hillaire-Buys D;
Ann Pharmacother; 2007 May; 41(5):755-63. PubMed ID: 17456542
[TBL] [Abstract][Full Text] [Related]
7. Medication safety program reduces adverse drug events in a community hospital.
Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
[TBL] [Abstract][Full Text] [Related]
8. A pharmaceutical manufacturer's perspective on reporting adverse drug experiences.
Sullivan JW
Am J Hosp Pharm; 1990 Jun; 47(6):1342-5. PubMed ID: 2368728
[TBL] [Abstract][Full Text] [Related]
9. Effective interventions and implementation strategies to reduce adverse drug events in the Veterans Affairs (VA) system.
Mills PD; Neily J; Kinney LM; Bagian J; Weeks WB
Qual Saf Health Care; 2008 Feb; 17(1):37-46. PubMed ID: 18245218
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for self-reported adverse drug events among Medicare enrollees.
Oladimeji O; Farris KB; Urmie JG; Doucette WR
Ann Pharmacother; 2008 Jan; 42(1):53-61. PubMed ID: 18029427
[TBL] [Abstract][Full Text] [Related]
11. Reporting adverse events in randomized controlled trials.
Nuovo J; Sather C
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):349-51. PubMed ID: 16998947
[TBL] [Abstract][Full Text] [Related]
12. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug events in hospitalized cardiac patients.
Fanikos J; Cina JL; Baroletti S; Fiumara K; Matta L; Goldhaber SZ
Am J Cardiol; 2007 Nov; 100(9):1465-9. PubMed ID: 17950809
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
[TBL] [Abstract][Full Text] [Related]
15. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
[TBL] [Abstract][Full Text] [Related]
16. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
Page RL; Ruscin JM
Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
[TBL] [Abstract][Full Text] [Related]
17. Adverse Drug Events Involving COX-2 Inhibitors.
Verrico MM; Weber RJ; McKaveney TP; Ansani NT; Towers AL
Ann Pharmacother; 2003 Sep; 37(9):1203-13. PubMed ID: 12921500
[TBL] [Abstract][Full Text] [Related]
18. Reliability evaluation of the adapted national coordinating council medication error reporting and prevention (NCC MERP) index.
Snyder RA; Abarca J; Meza JL; Rothschild JM; Rizos A; Bates DW
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1006-13. PubMed ID: 17523185
[TBL] [Abstract][Full Text] [Related]
19. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
20. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
Blenkinsopp A; Wilkie P; Wang M; Routledge PA
Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
